CMPX stock

Compass Therapeutics Inc. (CMPX) financials · $367.4M cap

Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT

Compass Therapeutics Inc. (CMPX) $367.4M cap.

Cached annual income statement
LineFY2025FY2024
RevenueN/A$850.0K
Operating Income-$72.8M-$56.6M
Net Income-$66.5M-$49.4M
EPS (Diluted)-$0.42-$0.36
Cached annual balance sheet
LineFY2025FY2024
Total Assets$219.6M$140.4M
Current Assets$209.8M$132.8M
Cash & Equivalents$30.6M$43.5M
PP&E$102.0K$353.0K
Total Liabilities$22.8M$15.2M
Current Liabilities$14.0M$8.87M
Shareholders' Equity$196.8M$125.2M
Retained Earnings-$431.2M-$364.7M
Cached annual cash flow
LineFY2025FY2024
Operating Cash Flow-$49.1M-$44.9M
CapEx$25.0K$44.0K
Investing Cash Flow-$93.3M$46.8M
Financing Cash Flow$129.6M$17.3M
Net Change in Cash-$12.8M$19.3M
Free Cash Flow-$49.2M-$44.9M
These statements as JSON? API free 100/day

FAQ

What is CMPX P/E and revenue?

Compass Therapeutics Inc. (CMPX) $367.4M cap.

What is CMPX revenue?

CMPX income-statement cache has no revenue figure yet.

Is CMPX profitable?

Compass Therapeutics Inc. last cached net income is -$66.5M (FY2025).

What are CMPX total assets?

Compass Therapeutics Inc. last cached total assets are $219.6M (FY2025).

What is CMPX free cash flow?

Compass Therapeutics Inc. last cached free cash flow is -$49.2M (FY2025).

Not investment advice. Cached statements, not a live tape.